摘要
目的以槲皮素(QT)为模型药,制备一种可再分散的槲皮素纳米晶自稳定Pickering乳液冻干粉(quercetin nanocrystals self-stabilized Pickering emulsion lyophilized powder,QT-NSSPE-LP)。方法采用高压均质法联合探头超声法制备QT-NSSPE,随后通过冻干技术实现其脱水固化得到QT-NSSPE-LP。以外观性状、复溶粒径和再分散指数(RDI)为评价指标,采用单因素试验筛选出QT-NSSPE-LP的优化处方,对优化条件得到的QT-NSSPE-LP进行表征和体外溶出评价。结果得到的QT-NSSPE-LP复溶粒径为(19.55±O.29)Mm,RDI为1.231±0.019;SEM和荧光显微镜结果表明冻干和再分散过程并未破坏QT-NSSPE-LP的形态结构。X-射线衍射结果表明QT-NSSPE-LP中QT的结晶度比原料药降低。体外溶出显示QT-NSSPE-LP的溶出度显著高于QT原料药。结论QT-NSSPE的固化可以通过冻干技术制备,能较好地保留Pickering乳液的形态结构和性质,可以为QT的进一步开发提供参考。
Objective To develop a redispersible quercetin(QT)nanocrystalline self-stabilizing Pickering emulsion freeze-dried powder(QT-NSSPE-LP)with QT as a model drug.Methods QT-NSSPE was prepared using high-pressure homogenization and probe ultrasonic method before the freeze-drying method was employed to prepare QT-NSSPE-LP.With the appearance,reconstituted particle size,and redispersibility index(RDI)as evaluation indexes,the optimal prescription was screened out on a single factor test.QT-NSSPE-LP prepared under optimal conditions was characterized and evaluated in vitro.Results The redispersion size and RDI of the obtained QT-NSSPE-LP were(19.55±0.29)ym and 1.231±0.019,respectively.SEM and fluorescence microscopy results showed that the structure of QT-NSSPE-LP had not been destroyed in the process of freeze-drying and redispersion.X-ray diffraction showed that the crystallinity of QT in QT-NSSPE-LP was decreased compared with raw materials of QT.The result of the in vitro release experiment showed that QT-NSSPE-LP had a higher accumulative release rate than the raw materials of QT.Conclusion QT-NSSPE can be solidified using the freeze-drying technology,which can maintain the structure and property of Pickering emulsion.This study can provide reference for the further development of QT.
作者
王哲
车智慧
胡菲
沈成英
戴博
申宝德
袁海龙
WANG Zhe;CHE Zhi-hui;HU Fei;SHEN Cheng-ying;DAI Bo;SHEN Bao-de;YUAN Hai-long(College of Pharmacy,Chengdu University of Traditional Chinese Medicine,Chengdu 611137,China;Air Force Medical Center,PLA,Beijing 100142,China;Jiangxi Provincial People's Hospital,Nanchang 330004,China)
出处
《解放军药学学报》
CAS
2022年第2期100-105,共6页
Pharmaceutical Journal of Chinese People's Liberation Army
基金
国家自然科学基金项目(81803741,81873092,82174074)
军队后勤科研重点项目(BKJ15JOO5,BKJ16JO11)。